[3] Li G., Wu Y., Gao J., Li J., Zhao Y., Zhang Q.,
Synthesis, Physical Properties, and Anion Recognition of Two Novel Larger Azaacenes: Benzannelated Hexazaheptacene and Benzannelated N,N'-Dihydrohexazaheptacene,
Chem. Asian J.,
8: 1574-1578 (2013).
[15] Yang X., Hu F., Di H., Cheng X., Li D., Kan X., Zou X., Zhang Q.,
A Convenient Base-mediated Synthesis of 3-Aryol-4-methyl (or benzyl)-2-methylthio Furans from α-Oxo Ketene Dithioacetals and Propargyl Alcohols via Domino Coupling/Annulations,
Org. Biomol. Chem.,
12: 8947-8951 (2014).
[24] Hiromichi F., Naoyuki K., Yoshinari S., Yasushi N., Yasuyuki K.,
Concise Asymmetric Synthesis of a Model Compound, (4S,5S,6S)-6-(2,2-Dimethoxy)ethyl-4,5-epoxy-6-hydroxy-2-cyclohexenone, for the Cyclohexenone Core of Scyphostatin,
Tetrahedron Lett.,
43: 4825-4828 (2002).
[26] Mc Bride C., Renhowe P., Heise C., Jansen J., Lapointe G., Ma S., Pineda R., Vora J., Wiesmann M., Shafer C.,
Design and Structure–Activity Relationship of 3-Benzimidazol-2-yl-1H-indazoles as Inhibitors of Receptor Tyrosine Kinases,
Bioorg. Med. Chem. Lett.,
16: 3595-3599 (2006).
[27] Yamaguchi M., Maruyama N., Koga T., Kamei K., Akima M., Kuroki T., Hamana M., Ohi N.,
Novel Antiasthmatic Agents with Dual Activities of Thromboxane A2 Synthetase Inhibition and Bronchodilation. VI. Indazole Derivatives,
Chem. Pharm. Bull.,
43: 332-334 (1995).
[28] Gorge V., De L., Kim U.T., Jing L.,
Beverly C.,
Ronald M.K.,
Sena G.,
Lee T.B.,
Gilbert N.L.,
Matthew R.W.,
Kelly A.L.,
Susan E.-V.,
Soo S.K.,
George L.T.,
Nonsymmetric P2/P2‘ Cyclic Urea HIV Protease Inhibitors. Structure-activity Relationship, Bioavailability, and Resistance Profile of Monoindazole-Substituted P2 Analogues,
J. Med. Chem.,
41: 2411-2423 (1998).
[34] Romagnoli R., Baraldi P.G., Carrion M.D., Cara C.L., Cruz-Lopez O., Preti D.,
Design, Synthesis, and Biological Evaluation of Thiophene Analogues of Chalcones,
Bioorg. Med. Chem.,
16: 5367-5376 (2008).
[35] Lunardi F., Guzela M., Rodrigues A.T., Corre R., Eger-Mangrich I., Steindel M., Grisard E.C., Assreuy J., Calixto J.B., Santos A.R.S.,
Trypanocidal and Leishmanicidal Properties of Substitution-containing Chalcones,
Antimicrob. Agents. Chemother.,
47: 1449-1451 (2003).
[45] Voronin V.G., Polevaya O.Y., Mukhanova V.G., Landau M.A., Kolbanov V.M., Privol’neva T.P., Chugunov V.V., Lavertskaya E.F.,
Synthesis and Biological Activity of Spiro [cycloalkane-2-thiobarbituric] Acids,
Khim.-Farm. Zh.,
10: 43-46 (1976).
[52] Mousavi M.R., Maghsoodlou M.T., Hazeri N., Habibi-Khorassani S.M.,
A Simple, Economical, and Environmentally Benign Protocol for the Synthesis of [1,2,4]Triazolo[5,1-b]quinazolin-8(4H)-one and Hexahydro[4,5]benzimidazolo[2,1-b]quinazolinone Derivatives,
J. Iran. Chem. Soc.
12: 1419-1424 (2015).